Filter
5417
Filtered Results: 5417
Text search:
drug
development
Featured
Recommendations
466
New Publications
1486
Language
Document type
No document type
3388
Studies & Reports
813
Guidelines
638
Manuals
215
Strategic & Response Plan
156
Fact sheets
73
Training Material
71
Situation Updates
22
Infographics
14
Resource Platforms
10
Brochures
7
Online Courses
7
Dashboards/Maps
1
App
1
Videos
1
Countries / Regions
India
313
Global
178
Kenya
175
Ethiopia
132
South Africa
130
Uganda
128
Nigeria
116
Western and Central Europe
110
Nepal
101
Tanzania
95
Sierra Leone
91
Liberia
91
Zambia
87
Malawi
85
Myanmar / Burma
80
Africa
76
Ghana
72
Bangladesh
70
Latin America and the Carribbean
69
Rwanda
65
Ukraine
57
Eastern Europe
57
Philippines
52
Namibia
52
Zimbabwe
44
Asia
41
Cambodia
40
South–East Asia Region
39
Russia
38
Lesotho
37
Indonesia
32
Botswana
29
Congo, Democratic Republic of
28
Mozambique
26
Syria
24
Eswatini/ Swaziland
23
Senegal
22
Burkina Faso
20
Colombia
19
Germany
19
East and Southern Africa
18
West and Central Africa
17
Brazil
17
South Sudan
17
Cameroon
16
Middle East and North Africa
16
USA
15
Haiti
14
Tajikistan
13
Albania
12
Venezuela
12
Pakistan
11
Thailand
10
Guinea
10
China
9
Afghanistan
9
Eastern Europe and Central Asia
9
Vietnam
9
Georgia
9
Argentina
8
Sudan
8
Armenia
7
Paraguay
7
Moldova
7
Mexico
6
Laos
6
Western Pacific Region
6
Yemen
6
North Macedonia
5
Benin
5
Peru
5
Lebanon
5
Sri Lanka
5
Central African Republic
5
Iraq
5
El Salvador
4
Jordan
4
Jamaica
4
United Kingdom
4
Southern Africa
4
Bhutan
4
Somalia
4
Madagascar
4
Timor Leste/ East Timor
3
Turkey
3
Iran
3
Fiji
3
Kyrgyzstan
3
North America
3
Côte d’Ivoire / Ivory Coast
3
Bolivia
3
Papua New Guinea
3
Palestine
3
Mali
3
Angola
3
Libya
3
Serbia
2
Kazakhstan
2
Chile
2
Canada
2
Estonia
2
Uzbekistan
2
Morocco
2
Guinea-Bissau
2
Hungary
2
Saudi Arabia
2
France
2
Portugal
2
Spain
2
Belarus
2
Poland
2
Honduras
2
Ecuador
2
North Korea
1
Switzerland
1
Australia
1
Gambia
1
Singapore
1
Congo-Brazzaville
1
Niger
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Ireland
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Nicaragua
1
Egypt
1
Romania
1
Greece
1
Chad
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
2129
Clinical Guidelines
489
Public Health
272
Women & Child Health
216
Key Resources
107
Capacity Building
78
Pharmacy & Technologies
63
Annual Report MEDBOX
1
Toolboxes
HIV
620
Mental Health
547
TB
521
AMR
286
COVID-19
207
NTDs
185
Pharmacy
161
NCDs
116
Caregiver
105
Rapid Response
90
Ebola
80
Planetary Health
80
Refugee
70
Disability
65
Global Health Education
61
Conflict
58
Health Financing Toolbox
39
Natural Hazards
21
Polio
21
Specific Hazards
16
Zika
16
Cholera
15
Social Ethics
14
Health Financing
1
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o...
This publication is intended for professionals training or practicing in mental health and not for the general public. The opinions
expressed are those of the authors and do not necessarily represent the views of the Editor or IACAPAP. This publication seeks to
describe the best treatments and pra...
Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4).
Patel V, Chisholm D, Dua T, et al., editors.
Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14.
New assessment guidelines for measuring the overall impact of mental health problems in Latin America have served as a catalyst for countries to review their mental health policies. Latin American countries have taken various steps to address long-standing problems such as structural difficulties, s...
In an environment of stagnant donor funding and increasing private sector investment in low- and middle-income countries, actors in both the public and private sectors are increasingly interested in using blended finance approaches to catalyze new funding for global health and achieve health outcome...
This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent of a systemic parasitic disease. Methodology: These clinical practice guidelines were prepared following the WHO handbook for guideline dev...
Stronger collaboration, better health: global action plan for healthy lives and well-being for all
recommended
The overall objective of the Global Action Plan is to enhance collaboration among 12 global organizations engaged in health, development and humanitarian responses to accelerate country progress on the health-related SDG targets. The Plan presents a new approach to strengthening collaboration among ...
States have a moral and legal obligation—under the Universal Declaration of Human Rights, human rights treaties, the 2030 Agenda for Sustainable Development and other international obligations—to remove discriminatory laws and to enact laws that protect people from discrimination
AIDSFree Case study series
This publication is made possible by the generous support of the American people through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and the U.S. Agency for International Development (USAID) under the terms of Cooperative Agreement AID-OAA-A-14-00046...
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibiotics. The severity of the consequences is clear to ...
Antibiotic resistant bacteria are spreading at an alarming rate and some bacterial infections may once again be untreatable. Antibiotic resistance (ABR), conservatively calculated, causes more than 500 000 deaths every year. This number is projected to rise dramatically if radical actions are not ta...
Antimicrobial resistance (AMR) is a complex issue of global concern. AMR is not simply a problem of medical science being beaten by nature; human action and perverse incentives play a major role in its development. The misuse of antibiotics in the medical, veterinary and agricultural sectors, which ...
Antibiotic resistant bacteria are spreading at an alarming rate and some bacterial infections may once again be untreatable. Antibiotic resistance (ABR), conservatively calculated, causes more than 500 000 deaths every year. This number is projected to rise dramatically if radical actions are not ta...
Antimicrobial resistance (AMR) is a complex issue of global concern. AMR is not simply a problem of medical science being beaten by nature; human action and perverse incentives play a major role in its development. The misuse of antibiotics in the medical, veterinary and agricultural sectors, which ...
Despite the considerable improvement in global health, millions of people still lack access to quality health services, including access to effective antimicrobial medicines, or are impoverished as a result of health spending. At the same time, antimicrobial resistance – a consequence of overuse a...
Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There ...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
Antibiotic Stewardship (AS) is a coordinated program that promotes the appropriate use of antimicrobials to improve patient outcomes, reduce microbial resistance, and decrease the spread of multi-drug resistant organisms. In clinical settings, stewardship activities focus on measuring and improving ...
The purpose of this guidance is to assist WHO Member States, and other stakeholders, in the establishment and development of programmes of integrated surveillance of antimicrobial resistance in foodborne bacteria (i.e., bacteria commonly transmitted by food). In this guidance, “integrated surveill...
During this work, a survey on essential medicines availability was conducted. This article was first written on this subject for sharing the poor financial availability of the essential medicines in the hospital and secondly, a call for an action to be taken in improving hospital pharmacies developm...
